The Institute of Molecular Biology and Biotechnology (IMBB) of FORTH, is organizing to two lectures in the new field of "Systems Therapeutics Drug Discovery", which will be given by Prof. Manolis Dermitzakis and Prof. Nikos Katsanis, pioneers in this new and groundbreaking research area.

The lectures will take place -in english-on February 17, 2025 at 12:00 at G. Lianis amphitheater, FORTH central building.

Recent advances on translational research, based on the fields of molecular and cell biology, genetics, as well as systems biology and pharmacology, have led to a new era of drug discovery and development. Novel biotechnological tools envision to radically change the therapeutic approaches of diseases, now referred to as 'systems therapeutics’. Systems therapeutics, focusing on disease pathology rather than physiological processes, is targeting malfunctional biological networks instead of the conventional strategies that target specific proteins or signaling pathways which has resulted in drugs with limited efficacy. Furthermore, these therapeutics will advance precision medicine, offering personalized therapies to individual patient characteristics.

The systems therapeutic relies on mathematical modeling and pharmacogenomic information utilizing the artificial intelligence’s capability to integrate knowledge from different fields. These holistic approaches promise to radically evolve the drug development process and accelerate the path towards personalized medicine, improving the quality of life for patients as well reducing global disease burden.

IMBB will host two lectures from pioneers in the field of systems therapeutics to discuss the most recent advances in this new and revolutionary approach for drug discovery.